Emergence and spread of antibiotic resistance following exposure to antibiotics
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Within a susceptible wild-type population, a small fraction of cells, even <10(-9) , is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Lopez, D., Vlamakis, H., & Kolter, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000398 · Cited by 797
Molin, S., & Tolker-Nielsen, T. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00036-3 · Cited by 708
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Setting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 514
Enne, V. I., Livermore, D. M., Stephens, P., & Hall, L. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04519-0 · Cited by 486
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Persistence of antibiotic resistance in bacterial populations
Andersson, D. I., & Hughes, D. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00289.x · Cited by 435
Hassett, D. J., Ma, J., Elkins, J. G., McDermott, T. R., Ochsner, U. A., West, S. E. H., Huang, C., Fredericks, J., Burnett, S., Stewart, P. S., et al. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01672.x · Cited by 409
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
Kahlmeter, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg312 · Cited by 397
Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F., & Cantón, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4769-4775.2004 · Cited by 333
Gene Amplification and Adaptive Evolution in Bacteria
Andersson, D. I., & Hughes, D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134805 · Cited by 323
Blondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Gasink, L. B., Edelstein, P. H., Lautenbach, E., Synnestvedt, M., & Fishman, N. O. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/648451 · Cited by 306
Expanding the soil antibiotic resistome: exploring environmental diversity
D’Costa, V. M., Griffiths, E., & Wright, G. D. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.08.009 · Cited by 287
Dong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Hsueh, P.-R., Chen, W.-H., & Luh, K.-T. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.016 · Cited by 262
Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease
Martínez‐Solano, L., Macia, M. D., Fajardo, A., Oliver, A., & Martinez, J. L. (2008) · Clinical Infectious Diseases · doi:10.1086/593186 · Cited by 257
The role of mutators in the emergence of antibiotic-resistant bacteria
Chopra, I., O’Neill, A. J., & Miller, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00041-4 · Cited by 246
Increased mutability of Pseudomonas aeruginosa in biofilms
Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J., & Chopra, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn044 · Cited by 234
Antibiotic Resistance: An Ecological Imbalance
Levy, S. B. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470515358.ch1 · Cited by 229
Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N., & Molin, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01581-07 · Cited by 225
Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance
Eliopoulos, G. M., & Blazquez, J. (2003) · Clinical Infectious Diseases · doi:10.1086/378810 · Cited by 206
Antibiotic cycling or rotation: a systematic review of the evidence of efficacy
Brown, E. M., & Nathwani, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh482 · Cited by 201
Ciofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T., & Høiby, N. (2010) · Microbiology · doi:10.1099/mic.0.033993-0 · Cited by 201
Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., Theuretzbacher, U., & Turnidge, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.005 · Cited by 200
Meyer, E., Schwab, F., Schroeren-Boersch, B., & Gastmeier, P. (2010) · Critical Care · doi:10.1186/cc9062 · Cited by 196
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Low-level antibacterial resistance: a gateway to clinical resistance
Baquero, F. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0196 · Cited by 193
Valverde, A., Grill, F., Coque, T. M., Pintado, V., Baquero, F., Cantón, R., & Cobo, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01008-08 · Cited by 187
From pieces to patterns: evolutionary engineering in bacterial pathogens
Baquero, F. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro909 · Cited by 184
Antimicrobial Drug Use and Methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000
Monnet, D. L., MacKenzie, F. M., López-Lozano, J. M., Beyaert, A., Camacho, M., Wilson, R., Stuart, D., & Gould, I. M. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1008.020694 · Cited by 184
Tamma, P. D., & Cosgrove, S. E. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.011 · Cited by 183
Sundqvist, M., Geli, P., Andersson, D. I., Sjolund-Karlsson, M., Runehagen, A., Cars, H., Abelson-Storby, K., Cars, O., & Kahlmeter, G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp387 · Cited by 179
Antibiotic resistance : origins, evolution, selection, and spread
Chadwick, D. J., & Goode, J. A. (1997) · Medical Entomology and Zoology · Cited by 172
Mai‐Prochnow, A., Elío, P. L., Egan, S., Thomas, T., Webb, J. S., Sánchez-Amat, A., & Kjelleberg, S. J. (2008) · Journal of Bacteriology · doi:10.1128/jb.00549-08 · Cited by 168
Thi, T. D., Lopez, E., Rodriguez-Rojas, A., Rodriguez-Beltran, J., Couce, A., Guelfo, J. R., Castaneda-Garcia, A., & Blazquez, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq496 · Cited by 167
Morosini, M.-I., García-Castillo, M., Coque, T. M., Valverde, A., Novais, A., Loza, E., Baquero, F., & Cantón, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-06 · Cited by 166
Self-citationClinical significance of extended-spectrum β-lactamases
Rodríguez-Baño, J., & Pascual, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.671 · Cited by 163
Side effects of antibiotics on genetic variability
Couce, A., & Blázquez, J. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00165.x · Cited by 158
López, E., Elez, M., Matic, I., & Blázquez, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05642.x · Cited by 139
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications
Pallecchi, L., Bartoloni, A., Paradisi, F., & Rossolini, G. M. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.725 · Cited by 131
Negri, M.-C., Lipsitch, M., Blázquez, J., Levin, B. R., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2485-2491.2000 · Cited by 131
Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria
Fantin, B., Duval, X., Massias, L., Alavoine, L., Chau, F., Retout, S., Andremont, A., & Mentré, F. (2009) · The Journal of Infectious Diseases · doi:10.1086/600122 · Cited by 130
Dong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
Polk, R. E., Johnson, C. K., McClish, D. K., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/422647 · Cited by 127
Novais, Â., Comas, I., Baquero, F., Cantón, R., Coque, T. M., Moyá, A., Gónzález‐Candelas, F., & Galán, J. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000735 · Cited by 126
Self-citationOlofsson, S. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl135 · Cited by 124
The intrinsic resistome ofPseudomonas aeruginosato β-lactams
Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Hancock, R. E. W., & Martínez, J. L. (2011) · Virulence · doi:10.4161/viru.2.2.15014 · Cited by 123
Clinical implications of antimicrobial resistance for therapy
MacGowan, A. P., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn357 · Cited by 122
PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa
Blázquez, J., Gómez‐Gómez, J., Oliver, A., Juan, C., Kapur, V., & Martín, S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05366.x · Cited by 121
López‐Camacho, E., & Blázquez, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-09 · Cited by 121
Antimicrobial-Drug Use and Methicillin-Resistant Staphylococcus aureus
Monnet, D. L., & Møller, J. K. (2001) · Emerging infectious diseases · doi:10.3201/eid0701.010129 · Cited by 119
Multi-resistant Gram-negative bacilli: from epidemics to endemics
Cantón, R., Coque, T. M., & Baquero, F. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200308000-00003 · Cited by 118
Self-citationChallenges: Selective compartments for resistant microorganisms in antibiotic gradients
Baquero, F., & Negri, M. (1997) · BioEssays · doi:10.1002/bies.950190814 · Cited by 116
Tam, V. H., Louie, A., Deziel, M. R., Liu, W., Leary, R. H., & Drusano, G. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/430611 · Cited by 104
Mandsberg, L. F., Ciofu, O., Kirkby, N., Christiansen, L. E., Poulsen, H. E., & Høiby, N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00428-08 · Cited by 100
Antibiotic Rotation and Development of Gram-Negative Antibiotic Resistance
van Loon, H.-J., Vriens, M. R., Fluit, A. C., Troelstra, A., van der Werken, C., Verhoef, J., & Bonten, M. J. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-070oc · Cited by 96
Levin, B. R., & Udekwu, K. I. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-10 · Cited by 88
Breakpoints: current practice and future perspectives
Mouton, J. W. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00028-6 · Cited by 86
Aparicio, J. R., Such, J. M., Pascual, S., Arroyo, A., Plazas, J., Girona, E., Gutiérrez, A., de Vera, F., Palazón, J. M., Carnicer, F., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80225-6 · Cited by 85
Lee, S., Lee, E. S., Park, S. Y., Kim, S.-Y., Seo, Y.-H., & Cho, Y. K. (2004) · Infection Control · doi:10.1086/502304 · Cited by 78
Rodríguez-Martínez, J. M., Velasco, C., García, I., Cano, M. E., Martínez-Martínez, L., & Pascual, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-06 · Cited by 76
A unified anti-mutant dosing strategy
Zhao, X., & Drlica, K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn229 · Cited by 75
The 2009 Garrod Lecture: The evolution of antimicrobial resistance: a Darwinian perspective
SYKES, R. B. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq217 · Cited by 74
Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa
Hansen, G. T., Zhao, X., Drlica, K., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.10.005 · Cited by 66
Rodríguez-Rojas, A., & Blázquez, J. (2008) · Journal of Bacteriology · doi:10.1128/jb.01081-08 · Cited by 63
Ciba Foundation Symposium 207 ‐ Antibiotic Resistance: Origins, Evolution, Selection and Spread
(2007) · Novartis Foundation symposium · doi:10.1002/9780470515358 · Cited by 63
Baquero, F. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr214 · Cited by 56
Antibiotic heterogeneity: from concept to practice
Bal, A. M., Kumar, A., & Gould, I. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05867.x · Cited by 52
Prevention and Treatment of Staphylococcus Biofilms
Speziale, P., Visai, L., Rindi, S., Pietrocola, G., Provenza, G., & Provenzano, M. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848442 · Cited by 51
Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa
Smania, A. M., Segura, I., Pezza, R. J., Becerra, C., Albesa, I., & Argaraña, C. E. (2004) · Microbiology · doi:10.1099/mic.0.26751-0 · Cited by 50
Zhanel, G. G., Mayer, M. L., Laing, N. M., & Adam, H. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01620-05 · Cited by 50
Croisier, D., Etienne, M., Piroth, L., Bergoin, E., Lequeu, C., Portier, H., & Chavanet, P. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh393 · Cited by 49
Zhao, X., Eisner, W., Perl-Rosenthal, N., Kreiswirth, B. N., & Drlica, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1023-1027.2003 · Cited by 49
The interface between veterinary and human antibiotic use
Shryock, T. R., & Richwine, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05788.x · Cited by 46
Garcia-Migura, L., Liebana, E., & Jensen, L. B. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm186 · Cited by 41
Anonymous, C. (2008) · Eurosurveillance · doi:10.2807/ese.13.46.19035-en · Cited by 38
Tängdén, T., Eriksson, B., Melhus, Å., Svennblad, B., & Cars, O. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr053 · Cited by 37
Hansen, G. T., & Blondeau, J. M. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.5.484 · Cited by 36
Meyer, E., Lapatschek, M., Bechtold, A., Schwarzkopf, G., Gastmeier, P., & Schwab, F. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1355-6 · Cited by 35
Selection of very small differences in bacterial evolution.
Baquero, F., Negri, M.-C., Morosini, M.-I., & Blázquez, J. (1998) · PubMed · Cited by 24
Self-citationEvolutionary Biology of Drug Resistance
Baquero, F., & Cantón, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_2 · Cited by 12
Self-citationPrelog, M., Grif, K., Decristoforo, C., Würzner, R., Kiechl-Kohlendorfer, U., Brunner, A., Zimmerhackl, L. B., & Orth‐Höller, D. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0901-0 · Cited by 12
Andersson, D. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018588108 · Cited by 7
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
The role of bacterial biofilms in chronic infections
Bjarnsholt, T. (2013) · APMIS · doi:10.1111/apm.12099 · Cited by 1,080
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
“caused by the bacterium, it is called clinical resistance (Cantón and Morosini, 2011).”
BackgroundStrategies to Minimize Antibiotic Resistance
Lee, C.-R., Cho, I., Jeong, B., & Lee, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094274 · Cited by 446
Metadata
- Authors
- Cantón, R., & Morosini, M.-I.
- Venue
- FEMS Microbiology Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09
- Volume
- 35
- Issue
- 5
- Pages
- 977-991
- ISSN
- 0168-6445 (ISSN-L)
- 1574-6976
- OpenAlex
- W1539821149
- Cited by
- 351
- References
- 96
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.